Pre-Open Stock Movers 05/03: (MDP) (OCGN) (VIRX) Higher; (VXRT) (PETS) (EL) Lower (more...)
- S&P 500, Dow end at record highs as weak jobs data eases rate worries
- U.S. Added Only 266,000 Jobs in April, Well Below Estimates
- Roku (ROKU) Surges After Crushing Profit Estimates to Prompt an Upgrade to 'Buy' at Loop Capital
- Dollar broadly weaker after U.S. jobs data disappoint
- Square (SQ) Tops Q1 EPS by 25c
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Today's Pre-Open Stock Movers
Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) 33% HIGHER; adds to recent momentum gains.
Meredith Corporation (NYSE: MDP) 12.5% HIGHER; today announced that it has agreed to sell its Local Media Group ("LMG") to Gray Television, Inc. (NYSE: GTN) for $2.7 billion in cash and will focus exclusively on its National Media Group ("NMG") portfolio post-close. Under the terms of the transaction, Meredith's National Media Group will be spun out to shareholders as a standalone publicly traded company retaining the Meredith Corporation name, with shareholders receiving cash consideration per share of approximately $14.50 and 1-for-1 equity share in post-close Meredith. The transaction was unanimously approved by Meredith's and Gray's Board of Directors.
Ocugen, Inc. (NASDAQ: OCGN) 12.3% HIGHER; announced that in a new study, scientists at Indian Council of Medical Research (ICMR)-National Institute of Virology have found that COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2. As previously disclosed, a study conducted by ICMR also suggested that COVAXIN was effective against the UK variant, B.1.1.7, as well as the Indian double mutant variant, B.1.617. It is notable that the Brazilian variant, B1.128.2, contains the E484K mutation that was found in New York.
Vaxart, Inc. (NASDAQ: VXRT) 9% LOWER; recent momentum stock reports earnings, provides update
Viracta Therapeutics (NASDAQ: VIRX) 7.2% HIGHER; H.C. Wainwright initiates coverage with a Buy rating and $35 price target.
BioNTech SE (NASDAQ: BNTX) 6.6% HIGHER; vaccine stocks gain.
PetMed Express (NASDAQ: PETS) 4.5% LOWER; reported Q4 EPS of $0.34, $0.06 worse than the analyst estimate of $0.40. Revenue for the quarter came in at $71.68 million versus the consensus estimate of $74.03 million.
Estee Lauder (NYSE: EL) 3.8% LOWER; reported Q3 EPS of $1.62, $0.33 better than the analyst estimate of $1.29. Revenue for the quarter came in at $3.86 billion versus the consensus estimate of $3.92 billion. Estee Lauder sees FY2021 EPS of $6.05-$6.15, versus the consensus of $6.00.
Clorox (NYSE: CLX) 1.8% LOWER; Wells Fargo downgraded from Overweight to Underweight, PT $170 (from $240.00).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Expedia (EXPE) Flies Higher After Topping Analysts' Estimates, Analysts Raise Numbers and PT on 'Significant Outperformance'
- Tilray (TLRY) Spikes 10% Pre-Open Following Upgrade
- Pre-Open Stock Movers 05/04: (BLRX) (UFS) (TBBL) Higher; (SDC) (IRBT) (MAXR) Lower (more...)
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesEarnings, Wells Fargo, Pre-Open Losers, Pre-Open Winners, Pre Market Movers, H.C. Wainwright
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!